Hemophilia SNF Access Act

Bill: 116-s-3233
Sponsor: full_name: Sen. Menendez, Robert [D-NJ]
Introduced: 2020-01-28
Policy area: Health
Subjects: Blood and blood diseases

Health care coverage and access

Long-term, rehabilitative, and terminal care

Medicare
Latest action: action_date: 2020-01-28
text: Read twice and referred to the Committee on Finance.

Summaries:
action_date: 2020-01-28
action_desc: Introduced in Senate
text: <p><b>Hemophilia SNF Access Act</b></p> <p>This bill includes certain treatments for hemophilia and other bleeding disorders as high-cost, low-probability ancillary services that may be paid for separately, rather than under the prospective payment (i.e., per diem) system for skilled nursing facilities, under Medicare.</p>

tv_txt: II 116th CONGRESS 2d Session S. 3233 IN THE SENATE OF THE UNITED STATES January 28, 2020 Mr. Menendez (for himself, Mr. Enzi , and Mr. Whitehouse ) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To amend title XVIII of the Social Security Act to improve access to skilled nursing facility services for hemophilia patients.

1. Short title This Act may be cited as the Hemophilia SNF Access Act . 2. Improving access to skilled nursing facility services for hemophilia patients (a) In general Section 1888(e)(2)(A)(iii) of the Social Security Act ( 42 U.S.C. 1395yy(e)(2)(A)(iii) ) is amended by adding at the end the following: (VI) Blood clotting factors and other medications indicated for the treatment of patients with hemophilia and other bleeding disorders (identified as of January 1, 2020, by HCPCS codes J7170, J7175, J7179, J7180–J7183, J7185–J7203, J7205, J7207, J7209–J7211 (and as subsequently modified by the Secretary)) and the separate payment amount for items and services related to the furnishing of such factors under section 1842(o)(5)(C). . (b) Effective date The amendments made by subsection (a) shall apply to items and services furnished on or after January 1, 2021.